Immuron (IMRN) Notes Payables (2017 - 2019)
Immuron (IMRN) posted quarterly Notes Payables of $98120.0 for Q4 2019, down 6.61% quarter-over-quarter from $105067.3 in Q2 2017.
Immuron (IMRN) Notes Payables (2017 - 2019) Analysis & Trends
Immuron's Notes Payables history runs 2 years deep, the most recent figure standing at $98120.0 for Q4 2019.
- In Q4 2019, Notes Payables changed N/A year-over-year to $98120.0; the TTM figure through Dec 2019 stood at $98120.0 (changed N/A YoY), while the FY2019 annual figure was $98120.0, changed N/A from the prior year.
- Notes Payables for Q4 2019 stood at $98120.0, down from $105067.3 in the prior quarter.
- The five-year high for Notes Payables was $105067.3 in Q2 2017, with the low at $98120.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 98,120.00 |
| Jun 30, 2017 | 105,067.28 |